PHIO PHARMACEUTICALS CORP. Temporary Equity, Liquidation Preference
PHIO PHARMACEUTICALS CORP. (PHIO) had Temporary Equity, Liquidation Preference of $9.90 million as of 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Balance Sheet › Equity
us-gaap:TemporaryEquityLiquidationPreference · last filed 2013-05-15
- 2013-03-31: Temporary Equity, Liquidation Preference $9.90M.
- 2012-12-31: Temporary Equity, Liquidation Preference $9.73M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2013-03-31 | $9.90M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $9.73M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |